Sven Kili

Company: Antion Biosciences SA

Job title: CEO

Seminars:

Multiplex Engineering Using the miCAR Platform Yields Persistent, Highly Active and Cost-Effective Cell Therapies 1:45 pm

Moving beyond editing to engineer immune cells Engineering cells which are less prone to exhaustion whilst maintaining efficacy Simplified, cost effective manufacturing improves CoGsRead more

day: Bootcamp Day

Industry Leaders’ Fireside Chat: Allogeneic Therapies Take on Europe 8:45 am

Reviewing clinical and preclinical trials in European allogeneic cell therapies to highlight developmental benefits Touching on the unique challenges of the European field, including market access, regulatory and capacity difficulties, to reveal the practical and strategic considerations for successful development Celebrating European allogeneic advances to encourage further expansion of the fieldRead more

day: Day One